Bristol-Myers Squib

May 5, 2015May 5, 2015

New Drug Shows Promise In Treating Chronic HCV Patients With Liver Transplant And Advanced Liver Disease

Hepatitis C, News

Hepatitis C is one of the worst forms of liver diseases affecting people in the world today — around 3.2 million have HCV in the United States alone. Spread mostly from ... Read more

May 1, 2015May 1, 2015

ALLY-1 Clinical Trial Results Suggest Viable Chronic Hepatitis C Virus Treatment

Hepatitis C, News

In a recent press release from Bristol-Myers Squibb, officials announced the success of their ongoing phase III clinical trial, ALLY-1, in meeting its predicted end-points. The trial had been conducted among ... Read more